{
  "image_filename": "table_p13_det_12_007.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/table_p13_det_12_007.png",
  "image_type": "Table",
  "page_number": 13,
  "block_id": "det_12_007",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "A table listing trade names and manufacturers of quadrivalent influenza vaccines (Afluria, Fluarix, Flucelvax, FluLaval, Fluzone) alongside their dose volumes (\u00b5g HA per virus) for children aged 6 through 35 months The table only provides dose volumes for various quadrivalent influenza vaccines in young children and makes no mention of antigenic match, WHO or FDA strain selection, or the Flublok vaccine; therefore it does not support the claim Note: Analysis limited to visible dosing information; no strain matching data present",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table listing trade names and manufacturers of quadrivalent influenza vaccines (Afluria, Fluarix, Flucelvax, FluLaval, Fluzone) alongside their dose volumes (\u00b5g HA per virus) for children aged 6 through 35 months",
    "evidence_found": null,
    "reasoning": "The table only provides dose volumes for various quadrivalent influenza vaccines in young children and makes no mention of antigenic match, WHO or FDA strain selection, or the Flublok vaccine; therefore it does not support the claim",
    "confidence_notes": "Analysis limited to visible dosing information; no strain matching data present"
  }
}